108.77
price up icon0.84%   0.9569
 
loading
前日終値:
$107.81
開ける:
$107.41
24時間の取引高:
1.97M
Relative Volume:
0.15
時価総額:
$189.46B
収益:
$46.59B
当期純損益:
$5.41B
株価収益率:
35.16
EPS:
3.0938
ネットキャッシュフロー:
$7.38B
1週間 パフォーマンス:
+1.49%
1か月 パフォーマンス:
+15.74%
6か月 パフォーマンス:
-3.18%
1年 パフォーマンス:
-19.04%
1日の値動き範囲:
Value
$107.36
$109.09
1週間の範囲:
Value
$104.20
$109.09
52週間の値動き範囲:
Value
$81.97
$137.49

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1081)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
115,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2026-07-16
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

Compare ABT vs SYK, MDT, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ABT icon
ABT
Abbott Laboratories
108.77 182.00B 46.59B 5.41B 7.38B 3.0938
SYK icon
SYK
Stryker Corp
341.97 129.09B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
88.82 107.81B 36.36B 4.84B 5.43B 3.7261
BSX icon
BSX
Boston Scientific Corp
50.54 67.64B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
92.42 47.81B 6.30B 1.07B 1.09B 1.8406

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-22 ダウングレード Daiwa Securities Outperform → Neutral
2025-10-10 開始されました The Benchmark Company Buy
2025-07-18 アップグレード Jefferies Hold → Buy
2025-06-16 開始されました Leerink Partners Market Perform
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
Jul 28, 2026

Abbott Rides Key Diabetes, Oncology and Heart Care Innovation Trends - TradingView

Jul 28, 2026
pulisher
Jul 28, 2026

Implicity’s Next-Generation ILR ECG Analyzer Earns FDA Clearance - GlobeNewswire Inc.

Jul 28, 2026
pulisher
Jul 27, 2026

FRAUD AND MANIPULATION—N.D. Ill.: Abbott did not commit securities fraud over tainted baby formula - VitalLaw.com

Jul 27, 2026
pulisher
Jul 27, 2026

Abbott (ABT) Lands Exclusive Rights To FDA Approved Blood Based CRC Test - Yahoo Finance

Jul 27, 2026
pulisher
Jul 27, 2026

Freenome went public for $300 million, then scored a huge victory with colorectal cancer test - The Business Journals

Jul 27, 2026
pulisher
Jul 27, 2026

Abbott (ABT) Raised Its Profit Forecast. What’s Driving Its Growth? - Yahoo Finance

Jul 27, 2026
pulisher
Jul 27, 2026

Federal Judge Dismisses Abbott Shareholder Lawsuit Over 2022 Infant Formula Recall - Law Commentary

Jul 27, 2026
pulisher
Jul 27, 2026

Abbott Labs Shakes Investor Suit Over 2022 Infant Formula Recall - Bloomberg Law News

Jul 27, 2026
pulisher
Jul 27, 2026

FDA approves Freenome colorectal cancer blood test to be marketed by Abbott - Fierce Biotech

Jul 27, 2026
pulisher
Jul 27, 2026

FDA approves Freenome's blood test for colorectal cancer screening - Reuters

Jul 27, 2026
pulisher
Jul 27, 2026

Is Abbott Stock Attractive After Its Earnings and Guidance Update? - The Globe and Mail

Jul 27, 2026
pulisher
Jul 27, 2026

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S. - BioSpace

Jul 27, 2026
pulisher
Jul 27, 2026

Abbott (ABT) Introduces FDA-Approved SimpleScreen CRC for Colore - GuruFocus

Jul 27, 2026
pulisher
Jul 27, 2026

Abbott Laboratories (ABT) Fell as Guidance and Litigation Concerns Overshadowed Growth - Yahoo Finance

Jul 27, 2026
pulisher
Jul 27, 2026

Zacks Investment Ideas feature highlights: General Motors, Abbott Laboratories and Johnson & Johnson - The Globe and Mail

Jul 27, 2026
pulisher
Jul 27, 2026

Why Is Abbott Laboratories (NYSE:ABT) a Blue-Chip Stock to Watch? - Kalkine Media

Jul 27, 2026
pulisher
Jul 27, 2026

Abbott stock trades steady as investors weigh recent earnings and medical device growth - Ad-hoc-news.de

Jul 27, 2026
pulisher
Jul 26, 2026

Abbott Laboratories stock trades steadily as diagnostics and medical devices support earnings - Ad-hoc-news.de

Jul 26, 2026
pulisher
Jul 25, 2026

PRIVACY ALERT: Abbott Laboratories and Exact Sciences Corporation Under Investigation for Data Breach of Patient Records - Los Angeles Downtown News

Jul 25, 2026
pulisher
Jul 25, 2026

Abbott Laboratories (ABT) Could Be 14% Undervalued On Mixed Earnings And Growth Focus - simplywall.st

Jul 25, 2026
pulisher
Jul 25, 2026

Abbott defeats shareholder lawsuit over 2022 infant formula recall | Business Information & News | FE - Westlaw Today

Jul 25, 2026
pulisher
Jul 25, 2026

Health News Roundup: Abbott Wins Lawsuit, Measles Surge in the US, and More Updates - Devdiscourse

Jul 25, 2026
pulisher
Jul 25, 2026

Abbott Beats 'Supersized' Investor Suit Over Formula Recall - Law360

Jul 25, 2026
pulisher
Jul 24, 2026

Abbott Wins 7th Circ. Fight Over Baby Formula Warning - Law360

Jul 24, 2026
pulisher
Jul 24, 2026

Patient Sues Abbott Labs, Exact Sciences in Data Theft - BankInfoSecurity

Jul 24, 2026
pulisher
Jul 24, 2026

Abbott Notches Appellate Win in Bellwether Infant Formula Case - news.bloombergtax.com

Jul 24, 2026
pulisher
Jul 24, 2026

Abbott defeats shareholder lawsuit over 2022 infant formula recall - Reuters

Jul 24, 2026
pulisher
Jul 24, 2026

Q2 Earnings: Guidance Upgrades Push These 3 Stocks Higher - TradingView

Jul 24, 2026
pulisher
Jul 24, 2026

FreeStyle Libre 3 Class Action Lawsuit Alleges Abbott Sold Defective Glucose Monitors - AboutLawsuits.com

Jul 24, 2026
pulisher
Jul 24, 2026

Medtech Stocks Have Gotten Slammed. Why Abbott, Danaher, 4 More Are Bargains. - Barron's

Jul 24, 2026
pulisher
Jul 24, 2026

Abbott Laboratories stock trades steady as diagnostics and medical devices support earnings momentum - AD HOC NEWS

Jul 24, 2026
pulisher
Jul 23, 2026

Abbott Laboratories and Exact Sciences Corp Under Investigation for Data Breach of Patient Records - Schubert Jonckheer & Kolbe

Jul 23, 2026
pulisher
Jul 23, 2026

Abbott Labs Accused Of Lax Security Over Shinyhunters Hack - Law360

Jul 23, 2026
pulisher
Jul 23, 2026

Abbott Stock And 2 Dividend Ideas For Retirement Income - simplywall.st

Jul 23, 2026
pulisher
Jul 23, 2026

ISRG vs. ABT: Which MedTech Giant Is the Smarter Investment Now? - TradingView

Jul 23, 2026
pulisher
Jul 23, 2026

Abbott Faces Spine Stimulator Lawsuit Brought Jointly by 17 Injured Patients - AboutLawsuits.com

Jul 23, 2026
pulisher
Jul 23, 2026

Abbott Laboratories (NYSE:ABT) Faces A Profit Test - Kalkine Media

Jul 23, 2026
pulisher
Jul 23, 2026

Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating - marketscreener.com

Jul 23, 2026
pulisher
Jul 23, 2026

Same Industry, Less Money: What Boston Scientific and ResMed Offer That Abbott Laboratories Does Not - Trefis

Jul 23, 2026
pulisher
Jul 23, 2026

Abbott Laboratories (ABT) Is Up 12.7% After Revenue Rises But Earnings Shrink In Q2 2026 - simplywall.st

Jul 23, 2026
pulisher
Jul 22, 2026

Abbott Laboratories (ABT) Earnings Drew Fresh Attention, Is It Still Below Fair Value? - Yahoo Finance

Jul 22, 2026
pulisher
Jul 22, 2026

Abbott Laboratories stock holds gains after strong diagnostics and medical devices momentum - Ad-hoc-news.de

Jul 22, 2026
pulisher
Jul 22, 2026

Abbott Laboratories (ABT) Stock Forecasts - Yahoo Finance

Jul 22, 2026
pulisher
Jul 22, 2026

Abbott (NYSE:ABT) Faces A Crucial Valuation Test - Kalkine Media

Jul 22, 2026
pulisher
Jul 22, 2026

Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating - marketscreener.com

Jul 22, 2026
pulisher
Jul 22, 2026

Cancer Diagnostics Breached At Abbott As 2026 Medtech Cyberattack Run Continues - insights.citeline.com

Jul 22, 2026
pulisher
Jul 22, 2026

Abbott (ABT) Stock May Be 32% Undervalued As Legal Overhang Fades - simplywall.st

Jul 22, 2026
pulisher
Jul 21, 2026

Abbott Laboratories stock steadies as medical devices and diagnostics underpin growth - Ad-hoc-news.de

Jul 21, 2026
pulisher
Jul 21, 2026

Abbott Laboratories stock underperforms Tuesday when compared to competitors - MarketWatch

Jul 21, 2026
pulisher
Jul 21, 2026

Patients sue diagnostics company over data breach - Courthouse News

Jul 21, 2026
pulisher
Jul 21, 2026

Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories - Yahoo Finance

Jul 21, 2026

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
SYK SYK
$342.05
price up icon 0.89%
MDT MDT
$87.59
price up icon 0.55%
BSX BSX
$50.59
price up icon 2.47%
EW EW
$92.04
price up icon 2.67%
$85.45
price up icon 0.82%
大文字化:     |  ボリューム (24 時間):